This article is more than 5 years old. Information may no longer be current.

Postop comfort trial for epi-LASIK commences

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

DELUTH, Ga. — A 3-month study assessing postoperative comfort and visual recovery in patients undergoing wavefront-guided custom ablations with the epi-LASIK technique has begun, according to a press release from Norwood EyeCare.

A maximum of 35 patients will be enrolled at each of 3 U.S. study sites, the press release said. The surgery will be either bilateral or single eye; in patients with bilateral treatment, both eyes will be treated at the same time, the company said. Patients with previous ocular surgery will be excluded from the trial.

Patients will be examined 1 day postoperatively until re-epithelialization occurs, at 3 to 6 weeks postop and at 10 to 15 weeks postop to measure comfort and visual recovery. Wavefront measurements will also be performed during the follow-up period.